Kuo MT - Search Results

1

Targeting the Copper Transport System to Improve Treatment Efficacies of Platinum-Containing Drugs in Cancer Chemotherapy.

Kuo MT, Huang YF, Chou CY, Chen HHW. Kuo MT, et al. Pharmaceuticals (Basel). 2021 Jun 8;14(6):549. doi: 10.3390/ph14060549. Pharmaceuticals (Basel). 2021. PMID: 34201235 Free PMC article. Review.

2

Targeting the Proline-Glutamine-Asparagine-Arginine Metabolic Axis in Amino Acid Starvation Cancer Therapy.

Kuo MT, Chen HHW, Feun LG, Savaraj N. Kuo MT, et al. Pharmaceuticals (Basel). 2021 Jan 18;14(1):72. doi: 10.3390/ph14010072. Pharmaceuticals (Basel). 2021. PMID: 33477430 Free PMC article. Review.

3

The roles of copper transporters in cisplatin resistance.

Kuo MT, Chen HH, Song IS, Savaraj N, Ishikawa T. Kuo MT, et al. Cancer Metastasis Rev. 2007 Mar;26(1):71-83. doi: 10.1007/s10555-007-9045-3. Cancer Metastasis Rev. 2007. PMID: 17318448 Review.

4

Role of glutathione in the regulation of Cisplatin resistance in cancer chemotherapy.

Chen HH, Kuo MT. Chen HH, et al. Among authors: kuo mt. Met Based Drugs. 2010;2010:430939. doi: 10.1155/2010/430939. Epub 2010 Sep 14. Met Based Drugs. 2010. PMID: 20885916 Free PMC article.

5

Predictive and prognostic value of human copper transporter 1 (hCtr1) in patients with stage III non-small-cell lung cancer receiving first-line platinum-based doublet chemotherapy.

Chen HH, Yan JJ, Chen WC, Kuo MT, Lai YH, Lai WW, Liu HS, Su WC. Chen HH, et al. Among authors: kuo mt. Lung Cancer. 2012 Feb;75(2):228-34. doi: 10.1016/j.lungcan.2011.06.011. Epub 2011 Jul 23. Lung Cancer. 2012. PMID: 21788094 Free PMC article.

6

Mechanistic basis for overcoming platinum resistance using copper chelating agents.

Liang ZD, Long Y, Tsai WB, Fu S, Kurzrock R, Gagea-Iurascu M, Zhang F, Chen HH, Hennessy BT, Mills GB, Savaraj N, Kuo MT. Liang ZD, et al. Among authors: kuo mt. Mol Cancer Ther. 2012 Nov;11(11):2483-94. doi: 10.1158/1535-7163.MCT-12-0580. Epub 2012 Aug 21. Mol Cancer Ther. 2012. PMID: 22914438 Free PMC article.

7

Role of the human high-affinity copper transporter in copper homeostasis regulation and cisplatin sensitivity in cancer chemotherapy.

Kuo MT, Fu S, Savaraj N, Chen HH. Kuo MT, et al. Cancer Res. 2012 Sep 15;72(18):4616-21. doi: 10.1158/0008-5472.CAN-12-0888. Epub 2012 Sep 7. Cancer Res. 2012. PMID: 22962276 Free PMC article. Review.

8

Overcoming platinum drug resistance with copper-lowering agents.

Chen HH, Kuo MT. Chen HH, et al. Among authors: kuo mt. Anticancer Res. 2013 Oct;33(10):4157-61. Anticancer Res. 2013. PMID: 24122978 Free PMC article. Review.

9

Regulation of the high-affinity copper transporter (hCtr1) expression by cisplatin and heavy metals.

Liang ZD, Long Y, Chen HH, Savaraj N, Kuo MT. Liang ZD, et al. Among authors: kuo mt. J Biol Inorg Chem. 2014 Jan;19(1):17-27. doi: 10.1007/s00775-013-1051-z. Epub 2013 Oct 17. J Biol Inorg Chem. 2014. PMID: 24132751 Free PMC article.

10

Targeting drug transport mechanisms for improving platinum-based cancer chemotherapy.

Chen HH, Chen WC, Liang ZD, Tsai WB, Long Y, Aiba I, Fu S, Broaddus R, Liu J, Feun LG, Savaraj N, Kuo MT. Chen HH, et al. Among authors: kuo mt. Expert Opin Ther Targets. 2015;19(10):1307-17. doi: 10.1517/14728222.2015.1043269. Epub 2015 May 25. Expert Opin Ther Targets. 2015. PMID: 26004625 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

231 results

Search Page